Loading...
Please wait, while we are loading the content...
Similar Documents
myelogenous leukemia poor-risk and elderly patients with previously untreated acute A phase 2 study of the farnesyltransferase inhibitor tipifarnib in
| Content Provider | Semantic Scholar |
|---|---|
| Author | Greenberg, Peter L. Wright, John Joseph Karp, Judith E. Bruzek, Laura M. Morris, Lawrence Adjei, Alex A. Kaufmann, Scott H. Lancet, Jeffrey E. Gojo, Ivana Gotlib, Jason Feldman, Eric J. Greer, Jacqueline Liesveld, Jane L. |
| Copyright Year | 2010 |
| Abstract | Garrett-Mayer, Peter L. Greenberg, John J. Wright and Judith E. Karp Laura M. Bruzek, Lawrence Morris, Youn Park, Alex A. Adjei, Scott H. Kaufmann, Elizabeth Jeffrey E. Lancet, Ivana Gojo, Jason Gotlib, Eric J. Feldman, Jacqueline Greer, Jane L. Liesveld, myelogenous leukemia poor-risk and elderly patients with previously untreated acute A phase 2 study of the farnesyltransferase inhibitor tipifarnib in |
| File Format | PDF HTM / HTML |
| Alternate Webpage(s) | http://bloodjournal.hematologylibrary.org/content/109/4/1387.full.pdf |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |